Pieris Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.13
|
0.03
|
18.75%
|
|
2022-06-30
|
-0.11
|
-0.14
|
-0.03
|
-27.27%
|
|
2022-03-31
|
-0.11
|
-0.07
|
0.04
|
36.36%
|
|
2021-12-31
|
-0.30
|
-0.13
|
0.17
|
56.67%
|
|
2021-09-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.26
|
-0.25
|
0.01
|
3.85%
|
|
2021-03-31
|
-0.17
|
-0.07
|
0.10
|
58.82%
|
|
2020-12-31
|
-0.24
|
-0.26
|
-0.02
|
-8.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.34
|
|
2021-12-31
|
-0.69
|
|
2020-12-31
|
-0.68
|
|
2019-12-31
|
-0.55
|
|
2018-12-31
|
-0.49
|
|
2017-12-31
|
-0.40
|
|
2016-12-31
|
-0.54
|
|
2015-12-31
|
-0.38
|
|
2014-12-31
|
-0.14
|